Problems and solutions to successful gene-transfer based therapies for HIV

Clinical and Applied Immunology Reviews

Volumn 3, Issue 4-5, 2003, Pages 199-211

  Zaia, John A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

AIDS; Gene delivery; Gene therapy; Gene transfer vector; HIV; Human immunodeficiency virus; Lymphoma; Stem cell; T lymphocyte

Indexed keywords

ANTIRETROVIRUS AGENT; CARMUSTINE; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY RNA; CYCLOPHOSPHAMIDE; DIPHTHERIA TOXIN; ETOPOSIDE; INTEGRASE; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; RETROVIRUS VECTOR; REV PROTEIN; RIBOZYME; STROMAL CELL DERIVED FACTOR 1; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENO ASSOCIATED VIRUS; ANTIVIRAL ACTIVITY; BONE MARROW; CELL MATURATION; CELL TRANSPORT; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; DENDRITIC CELL; DISEASE COURSE; DISEASE DURATION; DNA MODIFICATION; DRUG POTENCY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INFECTION CONTROL; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MACROPHAGE; NAUSEA AND VOMITING; PATHOGENESIS; REVIEW; SIMIAN VIRUS 40; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TARGET CELL; THYMUS; THYMUS FUNCTION; TRANSGENE; VIRUS IMMUNITY;

EID: 0141594977     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00157-5     Document Type: Review

References (54)

1. Baltimore D. Intracellular immunization Nature 335 1988 395-396
2. Smith K.Y. Valdez H. Landay A. Spritzler J. Kessler H.A. Connick E. et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy J Infect Dis 181 2000 141-147
3. Appay V. Nixon D.F. Donohoe S.M. Gillespie G.M. Dong T. King A. et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function J Exp Med 192 2000 63-75
4. Appay V. Papagno L. Spina C.A. Hansasuta P. King A. Jones L. et al. Dynamics of T cell responses in HIV infection J Immunol 168 2002 3660-3666
5. Champagne P. Ogg G.S. King A.S. Knabenhans C. Ellefsen K. Nobile M. et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes Nature 410 2001 106-111
6. Spiegel H.M. Ogg G.S. DeFalcon E. Sheehy M.E. Monard S. Haslett P.A. et al. Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells J Virol 74 2000 1018-1022
7. Appay V. Dunbar P.R. Callan M. Klenerman P. Gillespie G.M. Papagno L. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections Nat Med 8 2002 370-385
8. Zaia J.A. Cairns S.J. Sarver N. Genetic modification and transplantation of hematopoietic cells for treatment of human immunodeficiency virus infection. In: Donnall T.E. Blume K.G. Forman S.J. editors. Hematopoietic cell transplantation. 2nd ed. 1999 1105 1116 Blackwell Science; Oxford, England
9. Change H.K. Gendelman R. Lisziewicz J. Gallo R.C. Ensoli B. Bloci of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1 Gene Ther 1 1994 208-216
10. Kim J.H. McLinden R.J. Mosca J.D. Vahey M.T. Greene W.C. Redfield R.R. Inhibition of HIV-1 replication by sense and antisense rev response elements in HIV-based retroviral vectors J Acquir Immune Defic Syndr Hum Retrovirol 12 1996 343-351
11. Ho D.D. Pomerantz R.J. Kaplan J.C. Pathogenesis of infection with human immunodeficiency virus N Engl J Med 317 1987 278-286
12. Sullenger B.A. Gallardo H.F. Ungers G.E. Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Cell 63 1990 601-608
13. Rosenzweig M. Marks D.F. Hempel D. Johnson R. Lisziewicz J. et al. Transduction of CD34+ hematopoietic progenitor cells with an anti-tat gene protects T-cell and macrophage progeny from AIDS virus infection J Virol 71 1997 2740-2746
14. Morgan R.A. Walker R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins Hum Gene Ther 7 1996 1281-1306
15. Sarver N. Cantin E.M. Chang P.S. Zaia J.A. Ladne P.A. Stephens D.A. et al. Ribozymes as potential anti-HIV-1 therapeutic agents Science 247 1990 1222-1225
16. F cells from HIV-1 infected donors using retroviral vectors containing anti-HIV-1 genes Blood 89 1997 2259-2267
17. Woffendin C. Ranga U. Yang Z. Xu L. Nabel G.J. Expression of a protective gene prolongs survival of T-lymphocytes in human immunodeficiency virus-infected patients Proc Natl Acad Sci USA 93 1996 2889-2894
18. Range U. Woffendin C. Verma S. Xu L. June C.H. Bishop D.K. et al. Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals Proc Natl Acad Sci USA 95 1998 1201-1206
19. Chinen J. Aguilar-Cordova E. Ng-Tang D. Lewis D.E. Belmont J.W. Protection of primary human T-cells from HIV-1 infection by Trev: a transdominant fusion gene Hum Gene Ther 8 1997 861-868
20. Smith S.M. Markham R.B. Jeang K.T. Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function Proc Natl Acad Sci USA 93 1996 7955-7960
21. Curiel T.J. Cook D.R. Wang Y. Hahn B.H. Ghosh S.K. Harrison G.S. Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regluated diphtheria toxin A chain gene Hum Gene Ther 4 1993 741-747
22. Schness M.J. Johnson J.E. Buonocore L. Rose J.K. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection Cell 90 1997 849-857
23. Yang A.G. Chen S. Yao C. Huang X.F. Bai X. Phenotypic knockout of HIV-1 type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection Proc Natl Acad Sci USA 94 1997 11567-11572
24. Chen J.D. Bai X. Yang A.G. Cong Y. Chen S.Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy Nat Med 3 1997 1110-1116
25. Yang A.G. Zhang X. Torti F.J. Chen S.Y. Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes Hum Gene Ther 9 1998 2005-2018
26. Marasco W.A. Haweltine W.A. Chen S.-Y. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody Proc Natl Acad Sci USA 90 1993 7889-7893
27. Duan L. Bagasra O. Laughlin M.A. Oakes J.W. Pomerantz R.J. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody Proc Natl Acad Sci USA 91 1994 5075-5079
28. Levin R. Mhashilkar A.M. Dorfman T. Bukovsky A. Zani C. Bagley J. et al. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein Mol Med 3 1997 96-110
29. Rondon I.J. Marasco W.A. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases Annu Rev Microbiol 51 1997 257-283
30. Levy-Mintz P. Duan L. Zhang H. Hu B. Dornadula G. Zhu M. et al. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase J Virol 70 1996 8821-8832
31. Podsakoff G.M. Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector Mol Ther 4 2001 282-283
32. Bordignon C. Notarangelo L.D. Nobili N. Ferrari G. Casorati G. Panina P. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients Science 270 1995 470-475
33. Kohn D.B. Weinberg K.I. Nolta J.A. Heiss L.N. Lenarsky C. Crooks G.M. et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency Nat Med 1 1995 1017-1023
34. Poeschla E.M. Wong-Staal F. Looney D.J. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nat Med 4 1998 354-357
35. Zufferey R. Nagy D. Mandel R.J. Naldini L. Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 15 1997 871-875
36. Chatterjee S. Li W. Wong C. Lu D. Fisher-Adams G. Guha M. et al. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vector Blood 93 1999 1882-1894
37. Goins W.F. Krisky D.M. Wolfe D.P. Fink D.J. Glorioso J.C. Development of replication-defective herpes simplex virus vectors Methods Mol Med 69 2002 481-507
38. Strayer D.S. SV40-based gene therapy vectors: turning an adversary into a friend Curr Opin Mol Ther 2 2000 570-578
39. Miyoshi H. Smith K.A. Mosier D.E. Verma I.M. Torbett B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors Science 283 1999 682-685
40. Walker R.E. A phase I/II pilot study of the safety of the adoptive transfer of syngeneic gene-modified cytotoxic T lymphocytes in HIV-infected identical twins Hum Gene Ther 7 1996 367-400
41. Riddell S.R. Elliott M. Lewinsohn D.A. Gilbert M.J. Wilson L. Manley S.A. et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nat Med 2 1996 216-223
42. Mitsuyasu R.T. Anton P.A. Keeks S.G. Scadden D.T. Connick E. Downs M.T. et al. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects Blood 96 2000 785-793
43. Gabarre J. Azir N. Autran B. Katlama C. Leblond V. High-dose therapy and autologous hematopoietic stem cell transplantation for HIV-1 associated lymphoma Lancet 355 2000 1071-1072
44. Krishnan A. Molina A. Zaia J. Nademanee A. Kogut N. Rosenthal J. et al. Autologous stem cell transplantation for HIV-associated lymphoma Blood 98 2001 3857-3859
45. Aiuti A. Vai S. Mortellaro A. Casorati G. Ficara F. Andolfi G. et al. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement Nat Med 8 2002 423-425
46. Cavazzana-Calvo M. Hacein-Bey S. de Saint Basile G. Gross F. Yvon E. Nusbaum P. et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Science 288 2000 669-672
47. Dunbar C.E. Cottler-Fox M. O'Shaughnessy J.A. Doren S. Carter C. Berenson R. et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation Blood 85 1995 3048
48. Dunbar C.E. Young N.S. Gene marking and gene therapy directed at primary hematopoietic cells Curr Opin Hematol 3 1996 430-437
49. Richter J. Gene transfer to hematopoietic cells-the clinical experience Br J Haematol 59 1997 67-75
50. Peterson R. Kempler G. Barklis E. A stem cell-specific silencer in the primer-binding region of a retrovirus Mol Cell Biol 11 1991 1214-1221
51. Deisseroth A.B. Zu Z. Claxon D. Hanania E.G. Fu S. Ellerson D. et al. Genetic marking shows that Ph+ cells persent in autologous transplants of chronic myelogenous leukemia (CML) contributre to relapse after autologous bone marrow in CML Blood 85 1994 3068-3076
52. Molina A. Krishnan A.Y. Nademanee A. Zabner R. Sniecinski I. Zaia J. et al. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy Cancer 89 2000 680-689
53. Molina A. Popplewell L. Kashyap A. Krishnan A.Y. Nademanee A. et al. High-dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy Cancer 89 2000 680-689
54. Zaia JA. Rossi JJ. Krishnan AY. Ito JI. Castanotto D. Li S. et al. Autologous stem cell transplantation using retrovirus-transduced peripheral blood progenitor cells in HIV-infected persons: comparison of gene marking post-engraftment with and without myeloablative therapy. In: 41st Annual Meeting of the American Society of Hematology. New Orleans, Louisiana, 1999.